CERo Therapeutics Holdings, Inc. – NASDAQ:CEROW

CERo Therapeutics Holdings stock price today

$0.016
+0.00
+77.78%

CERo Therapeutics Holdings stock price monthly change

-55.00%
month

CERo Therapeutics Holdings stock price quarterly change

-55.00%
quarter

CERo Therapeutics Holdings key metrics

Market Cap
 455.87K
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 N/A
Revenue
 N/A
EBITDA
 N/A
Income
 N/A
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

CERo Therapeutics Holdings stock price history

CERo Therapeutics Holdings stock forecast

CERo Therapeutics Holdings financial statements

Profit Margin

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW): Profit margin
2023 0 -2.53K
CEROW income statement history

Debt to Assets

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW): Debt to assets
2023 8560610 22.75M 265.87%
CEROW balance sheet history

Cash Flow

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW): Cash Flow
2022 -1.09M 180.83M -138.70M
2023 -1.52K -7.94K -32.57K
CEROW cash flow history

CERo Therapeutics Holdings alternative data

CERo Therapeutics Holdings
Employees

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW): Employee count
Jun 2024 8
Jul 2024 8
Dec 2024 8

CERo Therapeutics Holdings other data

Frequently Asked Questions (FAQ)

  • What's the price of CERo Therapeutics Holdings stock today?

    One share of CERo Therapeutics Holdings stock can currently be purchased for approximately $0.02.

  • When is CERo Therapeutics Holdings's next earnings date?

    Unfortunately, CERo Therapeutics Holdings's (CEROW) next earnings date is currently unknown.

  • Does CERo Therapeutics Holdings pay dividends?

    No, CERo Therapeutics Holdings does not pay dividends.

  • How much money does CERo Therapeutics Holdings make?

    CERo Therapeutics Holdings has a market capitalization of 455.87K.

  • What is CERo Therapeutics Holdings's stock symbol?

    CERo Therapeutics Holdings, Inc. is traded on the NASDAQ under the ticker symbol "CEROW".

  • What is CERo Therapeutics Holdings's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of CERo Therapeutics Holdings?

    Shares of CERo Therapeutics Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does CERo Therapeutics Holdings have?

    As Dec 2024, CERo Therapeutics Holdings employs 8 workers.

  • What is CERo Therapeutics Holdings's official website?

    The official website for CERo Therapeutics Holdings is cero.bio.

  • Where are CERo Therapeutics Holdings's headquarters?

    CERo Therapeutics Holdings is headquartered at 201 Haskins Way, South San Francisco, CA.

  • How can i contact CERo Therapeutics Holdings?

    CERo Therapeutics Holdings's mailing address is 201 Haskins Way, South San Francisco, CA and company can be reached via phone at +65 04072376.

CERo Therapeutics Holdings company profile:

CERo Therapeutics Holdings, Inc.

cero.bio
Exchange:

NASDAQ

Full time employees:

8

Industry:

Biotechnology

Sector:

Healthcare

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.

+65 04072376
201 Haskins Way
South San Francisco, CA 94080

CIK: 0001870404
ISIN: US71902K1135
: